chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started with a sore throat pain on Saturday. I got very stuffed up and my nose was running. I was blowing my nose and coughing. By Sunday, I did not have a fever but I felt so bad on Sunday that I went back to bed. By late Sunday night, the cough seemed to come more from my  chest and bronchial area. I went to the doctor on Monday. I was put on a z-pack. Historically I've had many of these infections over the years, so I know once it starts getting bronchial. After taking the medication, I did start to feel better. I'm getting better but it's not quite over yet.
Patient developed itching at time of vaccine that worsened after taking a shower. On 3/5/14 developed full body rash and hives. Was seen in the ED, given Benadryl with good response and discharged home. Was doing well on 3/6/14.
My arm throbs or pulsates randomly.; My arm throbs or pulsates randomly.; Twitches in the muscle.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 19 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Sep2021 (Lot number: FC3183) at the age of 19 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "allergy" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FC3183, Location of injection: Arm Left), administration date: 23Aug2021, when the patient was 19 years old, for Covid-19 immunization. The following information was reported: LIMB DISCOMFORT (non-serious), MUSCLE SPASTICITY (non-serious) all with onset 16Sep2021, outcome "not recovered" and all described as "My arm throbs or pulsates randomly."; MUSCLE TWITCHING (non-serious) with onset 16Sep2021, outcome "not recovered", described as "Twitches in the muscle.". Therapeutic measures were not taken as a result of limb discomfort, muscle spasticity, muscle twitching.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination: Birth Control. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Known allergies: yes.  No follow-up attempts are possible. No further information is expected.
Rec'd vaccine 11-3-10 at 1215pm (thimerosal-free). At 645pm developed overwhelming itching; then hives on upper arm, below site of vaccine. 11-5-10 c/o dizziness, 3 welts under (L) arm. Applying BENADRYL cream locally. Referred to PMD.
This spontaneous report as received from a physician via a company representative refers to a patient of unknown age. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (Lot number, expiry date, route and dose were not reported). On an unknown date, the patient experienced itchy rash 5 to 10 days after vaccination which was diagnosed as chicken pox. The outcome of the reported event was unknown. Additional information has been requested.
Pt fainted after receiving vaccination. Hypotension 90/60 supine 104/90 sitting HR 50. Passed out a 2nd time. BP: 93/37 HR 50. No SOB, stridor, or difficulty breathing.
patient received Moderna COVID-19 vaccines on 4/12/2021 and 5/12/2021; subsequently tested positive for COVID at our hospital on 11/8/2021. The patient is admitted at our hospital NOT for COVID-19 related symptoms or issues, not requiring oxygen supplementation.
Around 10/15/2020 the employee noticed a limited range of motion due to pain in her left shoulder and arm.  Also started experiencing numbness in the left arm starting at the deltoid and traveling down to her fingers.  Employee states no pain when arm is not moved.  Greatest pain occurs when she reaches across her body.  The pain and numbness got worse over time.  Currently the employee is unable to buckle her seat belt or reach across her body without increased pain.
Received Varivax #2 on 7/10/2007 woke up 7/11/07 with red, swollen, tender to touch arm. Seen in office diagnosed with local reaction vs cellulitis secondary to Varivax. Treated with Keflex.
Began to feel funny 3 1/2 hours later. By 5 hours later I had terrible chills and was in bed. I was bedridden until 45 hours after the shot. Besides the chills and fatigue, I had a headache and backache.
IgG negative after completing vaccination series (1 moth after); This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (1 month after) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (1 month after). On 24-Mar-2021, SARS-COV-2 ANTIBODY TEST NEGATIVE (1 month after) had resolved. Not Provided    DIAGNOSTIC RESULTS: On 23-Mar-2021, SARS-CoV-2 antibody test: Negative.         No concomitant medications were provided.  No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-Aug-2021: Significant follow up appended. Patient race, weight, and height updated. Moderna Covid vaccine dose 1 and dose2, administration date and batch numbers were updated. On 12-Aug-2021: Follow up received.
did not develop immunity against the Hepatitis B virus; This case was reported by a nurse via call center representative and described the occurrence of therapy non-responder in a female patient who received Hepatitis B vaccine for prophylaxis.   On an unknown date, the patient received Hepatitis B vaccine at an unknown dose. On an unknown date, unknown after receiving Hepatitis B vaccine, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown.   It was unknown if the reporter considered the therapy non-responder to be related to Hepatitis B vaccine.  Additional details were provided as follows: No patients date of birth or vaccine data was provided. The registered nurse reported that the patient who received a full series of unknown brand of hepatitis B vaccine, and did not develop immunity against the Hepatitis B virus. The reporter consented to follow up. This case linked with US2020036858, reported by same reporter.      Lab Comments: lab test performed on unknown date
Injection site hot, hard and swollen. Swelling progressed down entire arm, unable to lift arm, watch band too tight to wear. Shake/fever 12/3/06 never had this before.
Initial report received on 04 December 2009 from a health care professional. A 52 year old female patient developed chills, fever, nausea, vomiting and ear pressure 48 hours after receiving H1N1 (lot number UP027AB) intramuscularly in the left deltoid on 02 December 2009. The patient did not recover at the time of the report. No further information was provided. List of Documents held by Sender: none.
This spontaneous report as received from an unspecified field employee via company representative refers to her son of unknown age. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. No previous drug reactions or allergies were reported. On an unknown date the patient was vaccinated with GARDASIL 9, (dosing details were not reported) (lot # and expiry date not reported) intramuscularly for prophylaxis. The reporter stated that on an unknown date her son had not been the same emotionally ever since (emotional disorder). The outcome of the event was unknown. Causality assessment was not reported. No product quality complaint involved.
pt recv vax 30APR97 & had a h/a;on the week of 12-16MAY felt hot & the evening of 16MAY a fever started the peak of which was 104.5;pt also had hot flashes & puffiness around the face & eyes;eyes were yellow & consulted a MD & was jaundiced
Difficulty breathing, requiring oxygen relief, a week after receiving vaccine to present.; This is a spontaneous report from a contactable consumer (patient). A 72-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation; Solution for injection, Lot Number: EL8982) via an unspecified route of administration in the right arm on 01Feb2021 at 10:30 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included chronic obstructive pulmonary disease and heart history. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Post the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. The patient's concomitant medications were not reported. On 08Feb2021, a week after receiving vaccine the patient experienced difficulty breathing. Treatment for the event was oxygen relief. The outcome of the event was not recovered.
Patient said that she was itchy after receiving the vaccine and weeks later had a rash and her back was hurting.
On 11/05/2003-employee reported 15 day history of swelling in right deltoid where influenza vaccine was administered; expressed concern.
A nurse reported that an 18 month old female received her 5th injection of Acel-Imune and subsequently, developed an injection site reaction characterized by "severe" swelling, redness and pain. No further information was available at the date of this report. This is 1 of 3 pts from this facility who developed an injection site reaction, following receipt of 2 different lots of Acel-Imune.
Site: Pain at Injection Site-Mild, Systemic: Allergic: Anaphylaxis-Mild, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash Generalized-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Systemic: Abdominal Pain-Mild, Systemic: Autoimmune Disease (diagnosed by MD)-Mild, Systemic: Bell's Palsy-Mild, Systemic: Blood Disorder  (diagnosed by MD)-Mild, Systemic: Body Aches Generalized-Mild, Systemic: Cardiac Disorder (diagnosed by MD)-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Chills-Mild, Systemic: Confusion-Mild, Systemic: Diarrhea-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Fever-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Heart Attack-Mild, Systemic: Hypertension-Mild, Systemic: Hyperventilation-Mild, Systemic: Hypotension-Mild, Systemic: Joint Pain-Mild, Systemic: Lymph Node Swelling-Mild, Systemic: MIS (Multisystem Inflammatory Syndrome)(diagnosed by MD)-Mild, Systemic: Nausea-Mild, Systemic: Neurological Disorder (diagnosed by MD)-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Seizure-Mild, Systemic: Shakiness-Mild, Systemic: Stroke-Mild, Systemic: Tachycardia-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Systemic: Tinnitus-Mild, Systemic: Unable to Sleep-Mild, Systemic: Visual Changes/Disturbances-Mild, Systemic: Vomiting-Mild, Systemic: Weakness-Mild, Additional Details: Dizziness, pale and feels like throwing up. Patient did not eat breakfast. NP had checked the patient in the Consultation room and his Blood Pressure was 104/64. Patient has Pfizer in the past
Emergency appendectomy  Followed by abcess at appendix site which required an additional surgery 22 days of IV antibiotics.
I was having grandmother of pt receiving immunizations hold his hands, as I was about to administer vaccine child started thrashing and kicking legs which resulted in grandmother being poked on leg with needle.
Extreme sweats Chills Severe Headache Cough Sinus issues  Restlessness   Has taken over the counter meds - not helping
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old male patient received BNT162b2 (BNT162B2), on 03May2022 at 10:15 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 38 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High cholesterol" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: COVID 19 Treatment; Positive, notes: symptoms returned and a positive test. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Adverse event: COVID rebound. I am only reporting to let you know I had a round on day seven after finishing medication. The medicine was incredible at treating my COVID symptoms. My rebound so far (now on day three since symptoms returned and a positive test) has been extremely mild and more like allergies. Congested nose feeling, occasional runny nose, feeling tired. So far easily treated with over the counter DayQuil.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Mild cellulitis; Headache; Sore arm; A spontaneous report was received from a nurse, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a sore arm, headache, and mild cellulitis.   The patient's medical history was not provided. Concomitant medications reported included calcium and memantine hydrochloride.   On 28 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 026L20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.   On 28 Dec 2020, after receiving the vaccine, the patient had a sore arm for 2-3 days. She was worried that she would get a headache so she took ibuprofen.   On 03 Jan 2021, the patient had a low-grade headache but it was not a migraine. She took acetaminophen and ibuprofen but it did not help.   On 04 Jan 2021, the patient's arm was a bit sore.   On 05 Jan 2021, the patient's headache went away but she felt she had mild cellulitis. Her arm felt a little bit warm at the injection site, it was also swollen and red. These symptoms persisted for about 2 days and then began to get better. Treatment for the events included ibuprofen, acetaminophen and icing.  Action taken with mRNA-1273 in response to the events was not reported.   The event, mild cellulitis, was considered resolving. The event, headache, was resolved on 05 Jan 2021. The outcome of the event, sore arm, was not reported.; Reporter's Comments: This case concerns a 67year old, female patient who experienced a serious unexpected event of cellulitis, and non-serious expected event of pain in extremity and headache. The event of pain in extremity occurred same day after first dose mRNA-1273 (Lot# 026L20A) administration. The event of headache occurred after 7 days and cellulitis occurred 9 days after mRNA-1273 (Lot# 026L20A) administration. The subject's concomitant medication included calcium and Biomentin. The treatment medications were included Tylenol, Advil and icing. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Moderna COVID 19 Vaccine EUA Over the weekend patient was very tired, had a headache that ran in to her neck and in to her right arm (injection site). Site was very swollen, hard, red hot. "It was about the size of a base ball". Fever (up to 101), chills, did take Tylenol and Ibuprofen for symptoms.
After patient received vaccine she C/O tingling face was given Benadryl  @1341 , 15 minutes later patient was C/O tight throat, Solumedrol 60mg IM administered to Rt buttocks by this nurse.  Pt then escorted to ER for further evaluation.  On 1/25/21 at 1359: Patient reported tingling of lips and throat felt tight.  SPO2 via finger with a result of 99%. Emergency room provider's note: 44-year-old female patient presents ED after allergic reaction.  Patient received her first COVID-19 vaccination and during the 15-minute observation period began to feel as if she had some tightness in her throat and difficulty swallowing.  She has a scratchy sensation to her posterior pharynx.  She denies specifically shortness of breath, nausea vomiting, dizziness or near syncope.  She was medicated with 50 mg of Benadryl p.o. as well as 60 mg of Solu-Medrol IM prior to arrival.  She states she has never previously had allergic reactions to vaccinations in the past
Pt had near syncope episode 24 hrs after vaccination and ? 72 hrs after vaccine. Mild anorexia with ?  and nausea.
Vaccine Administered Outside Protocol/Standing order Guidelines (The patient is 17). The patient did not experience any symptoms outside of the normal expected symptoms.
Initial information received on 17-Dec-2018 regarding an unsolicited valid non-serious case received from other health professional. This case involves Infant male patient who experienced shortness of breath and hives, while he received vaccine DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE. The patient's past medical history, medical treatments, vaccinations and family history were not provided. On an unknown date, the patient received a dose of suspect DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS (lot number and Expiry date unknown) via unknown route in unknown administration site. The patient developed a non-serious shortness of breath and hives (Unknown latency) following the administration of DIPHTHERIA and TETANUS AND ACELLULAR PERTUSSIS VACCINE. (Other relevant tests included No lab data.) Final diagnosis was hives and shortness of breath. It was not reported if the patient received a corrective treatment. The event outcome was reported as Unknown. List of documents held by sender: none.
Patient was given both immunization on right arm below usual injection site at 10 am. Pt returned to pharmacy later with a red, swollen arm that was warm to touch. Pt stated that her arm itched and was slightly painful. Pt was seen at urgent care and in ER. From photos from pt, the swelling extended down her right arm and hand. Returned to pharmacy a couple days later with signs of improvement/recovery.
Information has been received from a health professional concerning a 28 year old Caucassina male hospital phlebotomist who on 12/19/01 at 15:36 was vaccinated with a first dose of Varivax. On 01/02/02, the patient experienced a rash on his head, scalp and torso. The patient was seen by an occupational health physician who confirmed a classic case of chickenpox. There were 2 lesions on his abdomen and one lesion had a red center and was raised. The other lesions was pink and raised. There were additional lesions behind his right ear and on his scalp and back. Laboratory results revealed VZ IgG 0/14 on 12/11/2002. The patient indicated that he had not been exposed to anyone with chickenpox that he was aware of. He had no fever but felt flushed, fatigued and had a fluish neck pain but "not really sick feelings". The patient was asked if he had pus-like, fluid-leaking rash on his hands, arm or face and he reported that they were all dry and that they "itched a little bit". The varicella resolved on 01/11/02. No further information is available.
Information has been received from a physician concerning his 24 year old daughter who was vaccinated with the first dose of GARDASIL. Subsequently, the patient experienced general flu symptoms, but the adverse event had gone away. Several weeks ago, the patient received the second dose of GARDASIL. On approximately 27-OCT-2008 ("about 3 or 4 days ago"), the patient experienced arthralgia, myalgia, fever, and severe pain at the injection site. On 30-OCT-2008, the patient experienced having difficulty breathing with her asthma. The physician reported that the patient was not going to receive the third dosed of GARDASIL. At the time of reporting, the adverse events were ongoing. The patient sought medical attention via contacting physician. Additional information has been requested.
The initial case was missing the following minimum criteria: unspecified product. Upon receipt of follow-up information on 21Oct2016, this case now contains all required information to be considered valid. This is a spontaneous report obtained from a contactable pharmacist through a Pfizer sales representative. A female patient of an unspecified age and race, received, on an unknown date, PREVNAR 13 single dose, for immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, the patient experienced itching at the injection site. Clinical outcome was unknown at time of this report.
Numbness in right side of face, it worsened during the day , pain behind right ear, diagnosed with Bells Palsy.  Can close right eye 80%.
Shot on left deltoid - right inside ear itches & red patch under right arm pit itching & spreading down the arm. Pt advised to seek urgent care -  CLARITN - HC 1% cr - ice - fluids.
swelling in the arm; redness; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling in the arm) and VACCINATION SITE ERYTHEMA (redness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025821A and 010421A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer since an unknown date.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced PERIPHERAL SWELLING (swelling in the arm) and VACCINATION SITE ERYTHEMA (redness). At the time of the report, PERIPHERAL SWELLING (swelling in the arm) and VACCINATION SITE ERYTHEMA (redness) outcome was unknown.            Concomitant information were not reported. Treatment information were not reported.
I received the first two doses without incident but started experiencing Tinnitis most prominent in my left ear which is where I had the 3rd vaccination.
It was reported that a female pt received a Fluzone SV '99-'00 vaccination on 10/26/99. Reportedly on 10/29/99, the pt complained of left arm being sore and bruised. On 11/1/99, the pt complained of left side swelling of back. During the week of 12/8/99, the pt went to the Chiropractor and was treated with heat and electrical stimulation, which helped relax her back. On 11/27/99, the pt went to the ER and was referred to a vascular surgeon. On 12/6/99, the pt went to a vascular surgeon, who referred the pt to an Orthopedic Surgeon. The pt saw a MA on 12/27/99.
Patient did not have any adverse event. Patient was given pediatric dose instead of 12+ dose. Patient's parent were informed of the mix-up and that it is recommended for child to be immediately revaccinated with 12+ Pfizer dose based off CDC guidelines. Parent declined and stated "I do not feel comfortable having my child given another vaccine." Child will receive 12+ Pfizer dose on scheduled 2nd dose in 21 days.
Fever, chills, severe body aches on night 1. Left arm still sore 5 days later. Fatigue and brain fog still persistent. Body aches come and go.